Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: Comparison with cine magnetic resonance imaging

W. Gregory Hundley, Ali M. Kizilbash, Imran Afridi, Fatima Franco, Ronald M Peshock, Paul A. Grayburn

Research output: Contribution to journalArticle

190 Citations (Scopus)

Abstract

Objectives. The purpose of this study was to determine whether contrast- enhanced transthoracic echocardiography improves the evaluation of left ventricular (LV) volumes and ejection fraction (EF). Background. Echocardiographic assessment of LV volumes and EF is widely used but may be inaccurate when the endocardium is not completely visualized. Recently the intravenous (IV) administration of perfluorocarbon microbubbles has been shown to enhance opacification of the LV cavity, but the utility of these agents to improve the echocardiographic assessment of LV systolic function is unknown. Methods. In 40 subjects (29 men and 11 women, aged 24 to 81 years) an assessment of LV volumes and EF was performed with a magnetic resonance imaging examination, followed immediately by a transthoracic echocardiogram before and after the intravenous administration of 2% dodecafluoropentane emulsion (EchoGen; Sonus Pharmaceuticals, Bothell, Washington). Results. Contrast enhanced the echocardiographic assessment of LV end diastolic volume (p<0.02), end systolic volume (p< 0.01) and LVEF (p<0.03). The percentage of subjects in whom the correct echocardiographic classification EF was normal, mild to moderately depressed or severely reduced improved significantly after contrast enhancement (from 71% before contrast to 94% after, p<0.03). These findings were most striking in the subjects with two or more adjacent endocardial segments not visualized at baseline. Conclusions. Administration of an intravenous contrast agent improves the ability to accurately assess LV volumes and EF in humans. Contrast enhancement is most useful in subjects with two or more adjacent endocardial segments not seen at baseline.

Original languageEnglish (US)
Pages (from-to)1426-1432
Number of pages7
JournalJournal of the American College of Cardiology
Volume32
Issue number5
DOIs
StatePublished - Nov 1 1998

Fingerprint

Cine Magnetic Resonance Imaging
Fluorocarbons
Intravenous Administration
Stroke Volume
Contrast Media
Endocardium
Microbubbles
Emulsions
Left Ventricular Function
Echocardiography
Magnetic Resonance Imaging
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction : Comparison with cine magnetic resonance imaging. / Hundley, W. Gregory; Kizilbash, Ali M.; Afridi, Imran; Franco, Fatima; Peshock, Ronald M; Grayburn, Paul A.

In: Journal of the American College of Cardiology, Vol. 32, No. 5, 01.11.1998, p. 1426-1432.

Research output: Contribution to journalArticle

@article{5354a61ead394fce8e20037a050ce652,
title = "Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: Comparison with cine magnetic resonance imaging",
abstract = "Objectives. The purpose of this study was to determine whether contrast- enhanced transthoracic echocardiography improves the evaluation of left ventricular (LV) volumes and ejection fraction (EF). Background. Echocardiographic assessment of LV volumes and EF is widely used but may be inaccurate when the endocardium is not completely visualized. Recently the intravenous (IV) administration of perfluorocarbon microbubbles has been shown to enhance opacification of the LV cavity, but the utility of these agents to improve the echocardiographic assessment of LV systolic function is unknown. Methods. In 40 subjects (29 men and 11 women, aged 24 to 81 years) an assessment of LV volumes and EF was performed with a magnetic resonance imaging examination, followed immediately by a transthoracic echocardiogram before and after the intravenous administration of 2{\%} dodecafluoropentane emulsion (EchoGen; Sonus Pharmaceuticals, Bothell, Washington). Results. Contrast enhanced the echocardiographic assessment of LV end diastolic volume (p<0.02), end systolic volume (p< 0.01) and LVEF (p<0.03). The percentage of subjects in whom the correct echocardiographic classification EF was normal, mild to moderately depressed or severely reduced improved significantly after contrast enhancement (from 71{\%} before contrast to 94{\%} after, p<0.03). These findings were most striking in the subjects with two or more adjacent endocardial segments not visualized at baseline. Conclusions. Administration of an intravenous contrast agent improves the ability to accurately assess LV volumes and EF in humans. Contrast enhancement is most useful in subjects with two or more adjacent endocardial segments not seen at baseline.",
author = "Hundley, {W. Gregory} and Kizilbash, {Ali M.} and Imran Afridi and Fatima Franco and Peshock, {Ronald M} and Grayburn, {Paul A.}",
year = "1998",
month = "11",
day = "1",
doi = "10.1016/S0735-1097(98)00409-4",
language = "English (US)",
volume = "32",
pages = "1426--1432",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction

T2 - Comparison with cine magnetic resonance imaging

AU - Hundley, W. Gregory

AU - Kizilbash, Ali M.

AU - Afridi, Imran

AU - Franco, Fatima

AU - Peshock, Ronald M

AU - Grayburn, Paul A.

PY - 1998/11/1

Y1 - 1998/11/1

N2 - Objectives. The purpose of this study was to determine whether contrast- enhanced transthoracic echocardiography improves the evaluation of left ventricular (LV) volumes and ejection fraction (EF). Background. Echocardiographic assessment of LV volumes and EF is widely used but may be inaccurate when the endocardium is not completely visualized. Recently the intravenous (IV) administration of perfluorocarbon microbubbles has been shown to enhance opacification of the LV cavity, but the utility of these agents to improve the echocardiographic assessment of LV systolic function is unknown. Methods. In 40 subjects (29 men and 11 women, aged 24 to 81 years) an assessment of LV volumes and EF was performed with a magnetic resonance imaging examination, followed immediately by a transthoracic echocardiogram before and after the intravenous administration of 2% dodecafluoropentane emulsion (EchoGen; Sonus Pharmaceuticals, Bothell, Washington). Results. Contrast enhanced the echocardiographic assessment of LV end diastolic volume (p<0.02), end systolic volume (p< 0.01) and LVEF (p<0.03). The percentage of subjects in whom the correct echocardiographic classification EF was normal, mild to moderately depressed or severely reduced improved significantly after contrast enhancement (from 71% before contrast to 94% after, p<0.03). These findings were most striking in the subjects with two or more adjacent endocardial segments not visualized at baseline. Conclusions. Administration of an intravenous contrast agent improves the ability to accurately assess LV volumes and EF in humans. Contrast enhancement is most useful in subjects with two or more adjacent endocardial segments not seen at baseline.

AB - Objectives. The purpose of this study was to determine whether contrast- enhanced transthoracic echocardiography improves the evaluation of left ventricular (LV) volumes and ejection fraction (EF). Background. Echocardiographic assessment of LV volumes and EF is widely used but may be inaccurate when the endocardium is not completely visualized. Recently the intravenous (IV) administration of perfluorocarbon microbubbles has been shown to enhance opacification of the LV cavity, but the utility of these agents to improve the echocardiographic assessment of LV systolic function is unknown. Methods. In 40 subjects (29 men and 11 women, aged 24 to 81 years) an assessment of LV volumes and EF was performed with a magnetic resonance imaging examination, followed immediately by a transthoracic echocardiogram before and after the intravenous administration of 2% dodecafluoropentane emulsion (EchoGen; Sonus Pharmaceuticals, Bothell, Washington). Results. Contrast enhanced the echocardiographic assessment of LV end diastolic volume (p<0.02), end systolic volume (p< 0.01) and LVEF (p<0.03). The percentage of subjects in whom the correct echocardiographic classification EF was normal, mild to moderately depressed or severely reduced improved significantly after contrast enhancement (from 71% before contrast to 94% after, p<0.03). These findings were most striking in the subjects with two or more adjacent endocardial segments not visualized at baseline. Conclusions. Administration of an intravenous contrast agent improves the ability to accurately assess LV volumes and EF in humans. Contrast enhancement is most useful in subjects with two or more adjacent endocardial segments not seen at baseline.

UR - http://www.scopus.com/inward/record.url?scp=0032213369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032213369&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(98)00409-4

DO - 10.1016/S0735-1097(98)00409-4

M3 - Article

C2 - 9809958

AN - SCOPUS:0032213369

VL - 32

SP - 1426

EP - 1432

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 5

ER -